Please login to the form below

Not currently logged in
Email:
Password:

Save the Children

This page shows the latest Save the Children news and features for those working in and with pharma, biotech and healthcare.

Novartis and MMV to advance new malaria drug combination to phase 3 study

Novartis and MMV to advance new malaria drug combination to phase 3 study

A phase 2 study of ganaplacide/lumefantrine in 524 adults and children with acute uncomplicated malaria due to Plasmodium falciparum infection met its primary objective. ... If the phase 3 trial is successful, this new combination will increase the

Latest news

More from news
Approximately 1 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare (part 3) 30 Women Leaders in UK Healthcare (part 3)

    In 2012 Dr Williams created the GSK Maternal and Neonatal Health R&D Unit, and launched an innovative partnership with Save the Children to develop medicines specifically designed for use in ... As for more advanced tech, she says there are some great

  • Case study: RB Innovation Hack Case study: RB Innovation Hack

    Virgo partnered RB with Lions Health and Save the Children to create the RB Innovation Hack, a showcase event at the prestigious Cannes Lions International Festival of Creativity. ... at Save the Children India and hackathon judge.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Decibel Therapeutics expands leadership team Decibel Therapeutics expands leadership team

    He co-founded Bright Horizons Family Solutions, a worksite childcare and early education provider, and prior to this served as co-director of Save the Children's Sudan operations. ... a world in which the benefits and joys of hearing are available to all.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement
How does Pharma-HCP engagement need to evolve in today's digital landscape?...